Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Tipo de Pago: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
CS-274 fue aprobado por los Estados Unidos y la Unión Europea en 2003 se utilizará en combinación con otros medicamentos anti-eméticos para prevenir náuseas agudas o retrasadas durante el tratamiento inicial o repetido de los tumores y vómitos de vómitos altos o moderados.
PRODUCTOS POR GRUPO : Intermedios API > Intermedio para CAS 170729-80-3
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.